Study investigates immune system alterations in the brain

Jan 07, 2010

Using laboratory mice that had been bred to have brain changes similar to Alzheimer's disease, scientists were able to reduce two characteristic features of the disease by modifying the mice's immune systems with a special peptide (MOG45D) related to the myelin sheath that insulates nerve cells and nerve fibers. As a result, anti-inflammatory cells were recruited from the blood into the brain, dampening the local inflammatory response.

An article published online by the Journal of Neurochemistry describes the immune intervention, its cellular and molecular mechanisms of action, and the effects on disease pathology.

The study was conducted by scientists at the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center and the Weizmann Institute of Science in Rehovot, Israel. Michal Schwartz, Ph.D., the article's senior author, and Maya Koronyo-Hamaoui, Ph.D., first author, are available to provide additional details.

Schwartz is visiting professor at the Center of Neuroimmunology and Neurogenesis in the Department of Neurosurgery at Cedars-Sinai Medical Center and professor of neuroimmunology at the Weizmann Institute in Rehovot, Israel. Koronyo-Hamaoui is assistant professor and principal investigator in the Neuroimmunology Laboratory in the Department of Neurosurgery at Cedars-Sinai.

The most frequent cause of senile dementia, Alzheimer's disease is associated with the overproduction of beta-amyloid peptides - molecules that accumulate as sticky deposits in the brain. These "extra-cellular" plaques (accumulating on the exterior of neurons) damage the cells and interrupt cell-to-cell signaling. Abnormal protein tangles (neurofibrillary tangles) inside neurons also lead to cell dysfunction and death.

Researchers seek to defeat the disease in several ways: by preventing ; treating existing plaque deposits; and repairing or replacing injured neurons.

In this study, scientists modified the cellular and molecular immune environment in the brains of laboratory mice bred to model Alzheimer's disease with an altered myelin-derived peptide. This recruited anti-inflammatory cells into the brain, which diminished the effects of local and boosted the action of an enzyme that degrades plaque and is associated with glial scar formation.

Explore further: Lucid dreams and metacognition: Awareness of thinking—awareness of dreaming

Provided by Cedars-Sinai Medical Center

4 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Anti-inflammatory drug blocks brain plaques

Jun 24, 2008

Brain destruction in Alzheimer's disease is caused by the build-up of a protein called amyloid beta in the brain, which triggers damaging inflammation and the destruction of nerve cells. Scientists had previously shown that ...

Recommended for you

The brain's electrical alphabet

Jan 23, 2015

The brain's alphabet is a mix of rate and precise timing of electrical pulses: the observation was made by researchers at the International School for Advanced Studies (SISSA) of Trieste and the Italian Institute ...

Dragnet for epilepsy genes

Jan 23, 2015

An international team of scientists together with the University of Bonn Hospital have taken a new path in the research into causes of epilepsy: The researchers determined the networks of the active genes ...

The molecular biology behind ALS

Jan 23, 2015

UA researchers have identified a molecular defect in motor neurons that may help explain the mechanisms underlying ALS, or Lou Gehrig's Disease.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.